The estimated Net Worth of Mark S. Livingston is at least $3.18 Миллион dollars as of 4 March 2024. Mr Livingston owns over 20,627 units of Progyny Inc stock worth over $1,668,838 and over the last 4 years he sold PGNY stock worth over $652,467. In addition, he makes $857,006 as Chief Financial Officer at Progyny Inc.
Mr has made over 10 trades of the Progyny Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 20,627 units of PGNY stock worth $81,477 on 4 March 2024.
The largest trade he's ever made was exercising 44,064 units of Progyny Inc stock on 21 June 2021 worth over $228,252. On average, Mr trades about 4,670 units every 22 days since 2020. As of 4 March 2024 he still owns at least 72,875 units of Progyny Inc stock.
You can see the complete history of Mr Livingston stock trades at the bottom of the page.
Mark S. Livingston is the Chief Financial Officer at Progyny Inc.
As the Chief Financial Officer of Progyny Inc, the total compensation of Mr Livingston at Progyny Inc is $857,006. There are 4 executives at Progyny Inc getting paid more, with David Schlanger having the highest compensation of $4,964,200.
Mr Livingston is 55, he's been the Chief Financial Officer of Progyny Inc since . There are 7 older and 9 younger executives at Progyny Inc. The oldest executive at Progyny Inc is Norman Payson, 72, who is the Independent Director.
Mark's mailing address filed with the SEC is C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK, NY, 10018.
Over the last 5 years, insiders at Progyny Inc have traded over $949,717,514 worth of Progyny Inc stock and bought 76,923 units worth $999,999 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Plc Gsk и Gp A, Llcbonderman Davidcou.... On average, Progyny Inc executives and independent directors trade stock every 4 days with the average trade being worth of $2,005,422. The most recent stock trade was executed by Michael E Sturmer on 16 July 2024, trading 9,030 units of PGNY stock currently worth $270,900.
progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.
Progyny Inc executives and other stock owners filed with the SEC include: